NDAINJECTIONINJECTABLEPriority Review
Approved
Apr 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
Priority Review
Drug data last refreshed Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
INFED (iron dextran) is an injectable iron replacement therapy approved in 1974 for the treatment of anemia. It is a small-molecule iron compound administered via injection to replenish depleted iron stores in patients with iron-deficiency anemia. The drug works by providing bioavailable iron that the body utilizes for hemoglobin synthesis.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100) signals consolidation and potential team downsizing.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women
Started Jul 2013
74 enrolled
Pregnancy
Career Relevance
Working on INFED offers limited career advancement given its approaching loss of exclusivity, mature market position, and zero linked job openings. Roles focus on defensive market management, pricing negotiation, and formulary preservation rather than innovation or growth.
Brand Manager
Worked on INFED at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.